How much does Mounjaro go up to — and what does that mean for cost?

The myth: 'Mounjaro has one price'

The single biggest misconception about Mounjaro costs is that there is one figure to find and compare. There isn't. The medicine comes in six strengths (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg) and pricing typically steps up at each level. That means the cost you see quoted for a starter pen has no bearing on what you'll pay twelve months into treatment if you reach the higher doses. Providers price each strength separately, and the gap between the lowest and the highest can be substantial.

Treatment begins at 2.5mg because the first few weeks are about letting your system adjust, not delivering the full therapeutic effect. From there, your prescriber reviews progress and tolerance before moving up, usually in four-week steps. Reaching 15mg isn't guaranteed, some people respond well at lower doses and stay there. Others need the full escalation. A prescriber works through that with you; the pen selection follows the clinical picture, not the price comparison.

For a clear breakdown of how each individual strength is currently priced in the private market, the full Mounjaro cost guide on our treatment pages has the detail worth reading before you commit to any provider.

What headline prices leave out

Private weight-loss treatment is a crowded market and headline figures are rarely the whole story. A quoted price per pen sometimes excludes the initial consultation fee, the prescription charge, and delivery, costs that can easily add £30–£60 on top, depending on the provider. Some services charge a separate monthly platform or coaching fee. Others tie you into a subscription that auto-renews unless you cancel.

It's worth spending sixty seconds checking any provider on the GPhC register before handing over payment details, a registered pharmacy will have a visible premises registration number you can verify independently. That habit costs nothing and filters out a significant number of illegitimate sellers.

The Mounjaro price overview we publish breaks down what legitimate private costs look like across the dose range, including what changed after the September 2025 list-price revision. Eli Lilly's adjustment was significant, the highest-dose pen's reported list price moved from around £122 to around £330, as widely reported at the time. That shift fed through to private provider pricing across the board.

There is also the question of what you get for the money beyond the pen. Clinical support, aftercare access, and the confidence that what you're injecting came through the licensed UK supply chain are not line items that show up in a headline price comparison. They matter more than the difference between two similar quotes. The guide to private Mounjaro costs covers this in full.

Where nume sits, and why it's not the cheapest option

We're going to be direct: we don't compete on being the lowest price. That's a deliberate position, not an oversight. One transparent charge covers the consultation, the prescription, the medicine itself, and next-working-day DPD delivery, nothing added at checkout, no subscription, no auto-renewal. Every repeat order gets a fresh clinical review by a GPhC-registered Independent Prescriber before anything is dispensed. That infrastructure has a cost, and we'd rather be honest about it than bury it.

Our GPhC premises registration is 9012878, verifiable directly at the GPhC register. Medicines move through the licensed UK supply chain; Eli Lilly is an authorised supplier. For anyone thinking about what dose they might eventually reach and what that means for ongoing costs, the detail on whether Mounjaro prices increase with dose is a practical read before starting.

Current treatment pricing for each available strength is shown on our treatment consultation page. We don't print per-pen figures in body copy, the price shown there is the price you pay, with nothing hidden.

Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has warned publicly about counterfeit weight-loss pens sold online and via social media, and enforcement operations through 2025 seized roughly 20 million doses of illegally traded medicine at an estimated street value of around £45 million. Fake pens have been found to contain insulin rather than the labelled drug. A bargain pen from an unverified source is not a saving, it's a clinical risk.

For a medicine that requires a prescriber to assess your medical history, current medications, and weight trajectory before each dose step, the question isn't which provider is cheapest. It's which provider has a prescriber who will actually look at your case. NICE's appraisal of tirzepatide, TA1026, and the accompanying NHS England guidance on wraparound care both make clear that clinical oversight is part of what makes this treatment work safely over time. That oversight is what a legitimate provider is charging for.

If you want to understand how pricing shifts as the dose schedule progresses, the page on when Mounjaro pricing increases covers the titration timeline alongside the cost implications. And if your question is specifically about the top of the range, the guide to maximum Mounjaro costs addresses that directly. For clinical detail on the treatment itself, the Mounjaro overview is the place to start.